Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Sci Rep ; 10(1): 6478, 2020 04 15.
Article in English | MEDLINE | ID: mdl-32296104

ABSTRACT

Despite improvements in surgery and medical treatments, epithelial ovarian cancer (EOC) remains the most lethal gynaecological malignancy. Aim of this study is to investigate the preclinical immunotherapy activity of cytokine-induced killer lymphocytes (CIK) against epithelial ovarian cancers, focusing on platinum-resistant settings. We generated CIK ex vivo starting from human peripheral blood samples (PBMCs) collected from EOC patients. Their antitumor activity was tested in vitro and in vivo against platinum-resistant patient-derived ovarian cancer cells (pdOVCs) and a Patient Derived Xenograft (PDX), respectively. CIK were efficiently generated (48 fold median ex vivo expansion) from EOC patients; pdOVCs lines (n = 9) were successfully generated from metastatic ascites; the expression of CIK target molecules by pdOVC confirmed pre and post treatment in vitro with carboplatin. The results indicate that patient-derived CIK effectively killed autologous pdOVCs in vitro. Such intense activity was maintained against a subset of pdOVC that survived in vitro treatment with carboplatin. Moreover, CIK antitumor activity and tumor homing was confirmed in vivo within an EOC PDX model. Our preliminary data suggest that CIK are active in platinum resistant ovarian cancer models and should be therefore further investigated as a new therapeutic option in this extremely challenging setting.


Subject(s)
Carcinoma, Ovarian Epithelial/therapy , Cytokine-Induced Killer Cells/immunology , Immunotherapy/methods , Ovarian Neoplasms/therapy , Aged , Animals , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Carboplatin/pharmacology , Carboplatin/therapeutic use , Carcinoma, Ovarian Epithelial/blood , Carcinoma, Ovarian Epithelial/immunology , Carcinoma, Ovarian Epithelial/pathology , Cell Line, Tumor , Drug Resistance, Neoplasm , Female , Humans , Mice , Middle Aged , Ovarian Neoplasms/blood , Ovarian Neoplasms/immunology , Ovarian Neoplasms/pathology , Ovary/pathology , Primary Cell Culture , Xenograft Model Antitumor Assays
2.
Breast ; 38: 160-164, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29413403

ABSTRACT

BACKGROUND: Patients with metastatic breast cancer (MBC) can derive clinical benefit from several subsequent lines of chemotherapy. However, in heavily pre-treated patients, agents with clinical activity, a favourable side effects profile and a convenient administration modality are preferred. PATIENTS AND METHODS: We retrospectively analyzed 110 patients with previously treated MBC, who received oral etoposide at the dose of 50 mg/day for 20 days in 28 days cycles, between 2003 and 2017. Because this was not a prospectively planned study, to describe the clinical performance of oral etoposide we adopted the approach suggested by Dzimitrowicz and colleagues (J Clin Oncol. 2016; 34:3511-17); Tumour Response (TR) was defined as the proportion of physician-reported clinical or imaging response; Prolonged Duration on Therapy (PDT) as the proportion of non-progressing patients whose treatment lasted more than 6 months. Furthermore, we evaluated median duration on therapy (TD) and median Overall Survival (OS) by the Kaplan Meier method. RESULTS: The median number of previous chemotherapy lines was 5 (range 2-8). TR, PDT, median TD and median OS were 6.4%, 18.2% 4 (range 3.5-4.5) and 10.6 (range 8.4-12.8) months respectively. Interestingly, etoposide activity was unrelated to the number of previous lines and type of metastatic involvement. Oral etoposide was well tolerated with only two patients discontinuing therapy due to toxicity. CONCLUSIONS: In this large, single Institution, real practice analysis oral etoposide is a valuable and safe option for pre-treated metastatic breast cancer patients and might be considered in patients failing other approaches, but still suitable for chemotherapy.


Subject(s)
Antineoplastic Agents, Phytogenic/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Breast Neoplasms/drug therapy , Etoposide/administration & dosage , Administration, Oral , Adult , Aged , Aged, 80 and over , Breast Neoplasms/mortality , Breast Neoplasms/pathology , Drug Administration Schedule , Female , Humans , Kaplan-Meier Estimate , Middle Aged , Neoplasm Metastasis , Retrospective Studies , Treatment Outcome
3.
Plant Foods Hum Nutr ; 72(2): 156-160, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28161878

ABSTRACT

During the last few years, numerous attempts were made to identify effective α-glucosidase inhibitors from natural sources in order to develop new alternatives for diabetes management. Smallanthus sonchifolius (yacon) leaves were found to be effective in controlling postprandial hyperglycemia. Enhydrin, a constituent of yacon leaves, was noted for its significant hypoglycemic properties in diabetic rats. These properties were also demonstrated for yacon leaves decoction, which is rich in phenolic compounds such as chlorogenic acid and its derivatives. The purpose of the present study was to evaluate the potential of yacon leaves decoction and the isolated compound enhydrin to inhibit α-glucosidase enzyme, a possible mechanism of the above antihyperglycemic effect. In vitro assays showed that both 10% decoction and enhydrin significantly inhibited the activity of the yeast α-glucosidase enzyme in a dose-dependent manner, IC50 values being 50.40 and 134.17 µg/ml, respectively. In vivo experiments showed a rapid decrease in the hyperglycemic peak after sucrose load (2 g/kg body weight) in normal rats treated with the 10% decoction (140 mg/kg) and enhydrin (0.8 mg/kg). Both treatments caused a significant decrease in blood glucose levels in diabetic rats after sucrose load compared to diabetic control. These results suggest that both products assayed could be effective in the management of postprandial hyperglycemia through inhibition of α-glucosidase in the small intestine.


Subject(s)
Asteraceae/chemistry , Diabetes Mellitus, Experimental/drug therapy , Glycoside Hydrolase Inhibitors/pharmacology , Hyperglycemia/prevention & control , Hypoglycemic Agents/pharmacology , Sesquiterpenes/pharmacology , Animals , Chlorogenic Acid/isolation & purification , Chlorogenic Acid/pharmacology , Diabetes Mellitus, Experimental/chemically induced , Disease Models, Animal , Male , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Plant Leaves/chemistry , Rats , Rats, Wistar , Sesquiterpenes/chemistry , Sesquiterpenes/isolation & purification , Streptozocin/adverse effects , alpha-Glucosidases/metabolism
4.
Eur J Gynaecol Oncol ; 37(5): 638-643, 2016.
Article in English | MEDLINE | ID: mdl-29787001

ABSTRACT

INTRODUCTION: The best treatment for relapsed platinum sensitive epithelial ovarian cancer (EOC) is controversial. The aim of the study was to compare progression-free survival (PFS) and overall survival (OS) in platinum-sensitive EOC patients treated with chemotherapy alone (CTA), secondary cytoreductive surgery (SCR) or SCR plus hyperthermic intraperitoneal intraoperative chemotherapy (HIPEC). MATERIALS AND METHODS: Retrospective analysis of the clinical outcome of 46 EOC patients with at least 30 months of follow-up. RESULTS: Median follow-up time was 32 months for the CTA group, 30 months for the SCR group, and 45 months for the SCR + HIPEC group. Fifteen recurrences were observed in the CTA group, seven in the SCR group, and 16 in the SCR + HIPEC group. The median time elapsed between first and second recurrence (PFI-2) was significantly higher among patients treated with SCR + HIPEC, in comparison with patients treated with CTA (p = 0.012 andp = 0.017, respectively). On the contrary, PFI-2 did not significantly differ between the SCR and SCR + HIPEC groups (p = 0.877). A statistically significant difference in OS favouring SCR + HIPEC in comparison with CTA (p = 0.04) was observed. CONCLUSIONS: SCR HIPEC compared with CTA improves PFI-2 in patients with platinum-sensitive EOC recurrence. SCR + HIPEC might also improve OS in comparison with CTA. No improvement in favor of SCR + HIPEC vs SCR was observed,. These results further support the need of a randomized trial comparing chemotherapy with SCR ± HIPEC in this setting.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cytoreduction Surgical Procedures , Hyperthermia, Induced , Neoplasms, Glandular and Epithelial/therapy , Ovarian Neoplasms/therapy , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Carcinoma, Ovarian Epithelial , Combined Modality Therapy , Cytoreduction Surgical Procedures/adverse effects , Female , Humans , Hyperthermia, Induced/adverse effects , Middle Aged , Neoplasms, Glandular and Epithelial/mortality , Ovarian Neoplasms/mortality , Platinum/therapeutic use , Retrospective Studies
5.
Phytother Res ; 22(3): 303-7, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18058975

ABSTRACT

The hypoglycemic activity of a 70% methanol extract from the leaves of Ailanthus excelsa Roxb. (Simaroubaceae) was studied in normal, transiently hyperglycemic and streptozotocin (STZ)-induced diabetic rats. Oral administration of the extract at doses of 14, 70 and 350 mg/kg body weight caused no significant changes in fasting blood glucose levels of normal rats. In an oral glucose tolerance test, the extract produced a significant decrease in glycemia 90 min after the glucose pulse. Daily administration of A. excelsa extract for 60 days produced a significant hypoglycemic effect in diabetic animals. In addition, this treatment improved the altered renal function observed in diabetic control rats. This study suggests that Ailanthus leaf extract could be potentially useful for post-prandial hyperglycemia treatment.


Subject(s)
Ailanthus/chemistry , Blood Glucose/drug effects , Hypoglycemic Agents/pharmacology , Phytotherapy , Plant Extracts/pharmacology , Animals , Blood Glucose/analysis , Diabetes Mellitus, Experimental , Insulin/blood , Male , Methanol/chemistry , Plant Leaves/chemistry , Rats , Rats, Wistar , Sulfonylurea Compounds/pharmacology , Time Factors
6.
Biocell ; 27(1): 37-46, Apr. 2003.
Article in English | LILACS | ID: lil-384252

ABSTRACT

Amphibians respond to microbial infection through cellular and humoral defense mechanisms such as antimicrobial protein secretion. Most humoral defense proteins are synthetized in the skin. In this study we isolated two beta-galactoside-binding lectins with molecular weights of 50 and 56 KDa from the skin of Bufo arenarum. These lectins have significant hemagglutination activity against trypsinized rabbit erythrocytes, which was inhibited by galactose-containing saccharides. They are water-soluble and independent of the presence of calcium. The antimicrobial analysis for each lectin was performed. At mumolar concentration lectins show strong bacteriostatic activity against Gram negative bacteria (Escherichia coli K12 4100 and wild strains of Escherichia coli and Proteus morganii) and Gram positive bacteria (Enterococcus faecalis). The antibacterial activity of these lectins may provide an effective defense against invading microbes in the amphibian Bufo arenarum.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bufo arenarum/metabolism , Lectins/pharmacology , Skin/chemistry , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Bufo arenarum/anatomy & histology , Enterococcus faecalis/drug effects , Escherichia coli/drug effects , Hemagglutination Tests , Hemagglutinins/metabolism , Lactose/metabolism , Lectins/metabolism , Proteus/drug effects , Rabbits
7.
Biocell ; 27(1): 37-46, Apr. 2003.
Article in English | BINACIS | ID: bin-3979

ABSTRACT

Amphibians respond to microbial infection through cellular and humoral defense mechanisms such as antimicrobial protein secretion. Most humoral defense proteins are synthetized in the skin. In this study we isolated two beta-galactoside-binding lectins with molecular weights of 50 and 56 KDa from the skin of Bufo arenarum. These lectins have significant hemagglutination activity against trypsinized rabbit erythrocytes, which was inhibited by galactose-containing saccharides. They are water-soluble and independent of the presence of calcium. The antimicrobial analysis for each lectin was performed. At mumolar concentration lectins show strong bacteriostatic activity against Gram negative bacteria (Escherichia coli K12 4100 and wild strains of Escherichia coli and Proteus morganii) and Gram positive bacteria (Enterococcus faecalis). The antibacterial activity of these lectins may provide an effective defense against invading microbes in the amphibian Bufo arenarum. (AU)


Subject(s)
Comparative Study , RESEARCH SUPPORT, NON-U.S. GOVT , Anti-Bacterial Agents/pharmacology , Bufo arenarum/metabolism , Lectins/pharmacology , Skin/chemistry , Bufo arenarum/anatomy & histology , Enterococcus faecalis/drug effects , Escherichia coli/drug effects , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Hemagglutination Tests , Hemagglutinins/metabolism , Lactose/metabolism , Lectins/metabolism , Proteus/drug effects , Rabbits
8.
Lect. nutr ; 9(2): 68-72, jun. 2002. tab, graf
Article in Spanish | LILACS | ID: lil-424015

ABSTRACT

Antecedentes: hasta el momento, se desconoce la prevalencia de la desnutrición y del riesgo de la desnutrición en los pacientes internados en los hospitales generales de adultos del pais. Sólo existen informes parciales sobre desnutrición en afecciones médicas y en pacientes neoplásicos con y sin metástasis. Objetivos Conocer la prevalencia de la desnutrición y de riesgo de la desnutrición en pacientes internados en un hospital genera] de adultos (Hospital Pasteur, Montevideo, Uruguay) excluidas las áreas de medicina intensiva. 2. Determinar la constancia del diagnóstico nutricional en las historias clínicas de los pacientes. Material y métodos Encuesta sobre el estado nutricional de 179 pacientes internados en áreas médico-quirúrgicas no críticas del hospital, utilizando una Escala de Categorización Mutricional basada en la valoración global subjetiva (VGS) (A = bien nutridos; B = En riesgo de desnutrición; C= Desnutrición moderada; D = Desnutrición severa), cotejando su rendimiento con el índice de masa corporal (IMC) y la auditoría de las historias clínicas de los mismos pacientes, para determinar la constancia del diagnóstico nutricional y de peso-talla en las mismas. Resultados De los 179 pacientes encuestados, y de acuerdo a la escala propuesta, 39 (25 en C; 14 en D) estaban desnutridos (21.5 por ciento) y 37 (21 por ciento) estaban en riesgo de desnutrición (B). El IMC correspondiente a C y D es, de modo muy significativo, menor que el de A (p < 0.001). Sin embargo, A no es significativamente diferente de B, ni C lo es deD. En las 179 historias clínicas auditadas, sólo 24 (13.4 por ciento) tenían constancia del diagnóstico nutricional y ninguna presentó, en forma conjunta, los datos de peso y talla. Conclusiones Existe una alta prevalencia de desnutrición moderada-severa y de riesgo de desnutrición en la población hospitalaria encuestada, según la escala utilizada. Ésta se demostró más adecuada que el IMC per se para la categorización nutricional. Éste último no discrimina entre A y B ni entre C y D. Además, el IMC se altera en presencia de edemas y/o ascitis...


Subject(s)
Adult , Nutrition Disorders
9.
J Appl Toxicol ; 21(5): 417-23, 2001.
Article in English | MEDLINE | ID: mdl-11746185

ABSTRACT

Although the nephrotoxic effects of lead are well documented, the subcellular mechanisms of its action on the kidney remain unclear. The aim of the present work was to investigate the effects of chronic lead exposure on the expression of laminin-1 and fibronectin in the kidney of lead-treated rats. Western immunoblotting of the kidney extracts revealed that experimental exposure to lead resulted in a marked decrease in the intensity of the bands corresponding to laminin-1 and an increase in the intensity of the band corresponding to fibronectin. Immunohistochemical studies demonstrated a weak labelling to laminin-1 and a strong labelling to fibronectin in all renal basement membranes together with a decrease in their thickness. Other ultrastructural alterations found were a diminution in the amount of endothelial fenestrae, an increased fusion of foot processes in epithelial cells of the glomerulus and the presence of intranuclear inclusion bodies in the proximal tubule cells. Lead intoxication might be responsible for the above alterations in the renal extracellular matrix that could play an important role in the pathogenesis of lead nephropathy.


Subject(s)
Extracellular Matrix/drug effects , Kidney/drug effects , Lead/toxicity , Animals , Basement Membrane/drug effects , Basement Membrane/ultrastructure , Blotting, Western , Disease Models, Animal , Electrophoresis, Polyacrylamide Gel , Extracellular Matrix/ultrastructure , Fibronectins/biosynthesis , Immunoenzyme Techniques , Kidney/metabolism , Kidney Glomerulus/drug effects , Kidney Glomerulus/ultrastructure , Laminin/biosynthesis , Lead/blood , Lead Poisoning , Male , Rats , Rats, Sprague-Dawley
10.
Cell Biol Int ; 24(12): 881-8, 2000.
Article in English | MEDLINE | ID: mdl-11114237

ABSTRACT

Diabetes mellitus is characterized by anatomical and functional alterations of the intestinal tract. However, the aetiology of these disturbances remains unclear. The aim of the present work was to investigate the effects of diabetes on the expression of laminin-1 and fibronectin in the small intestine of Streptozotocin (STZ)-induced diabetic rats. The Western immunoblotting of the extracts from the small intestine revealed that experimental diabetes resulted in a marked increase in the intensity of the bands corresponding to laminin-1 and fibronectin. Immunohistochemical studies demonstrated a strong labelling to these two extracellular matrix (ECM) proteins in the small intestine of diabetic rats, mainly localized in the smooth muscle layer. These results occur together with a thickening of the basement membrane (BM) of the smooth muscle cells, demonstrated by transmission electron microscopy (TEM). We propose that the accumulation of ECM proteins in the smooth muscle layer may be an effect mediated by hyperglycaemia, since insulin treatment of diabetic rats reversed this accumulation. These results could provide information on the potential role of the ECM in the intestine, an organ which is known to exhibit important alterations in diabetes.


Subject(s)
Diabetes Mellitus, Experimental/metabolism , Extracellular Matrix Proteins/metabolism , Intestine, Small/metabolism , Muscle, Smooth/metabolism , Animals , Basement Membrane/metabolism , Basement Membrane/pathology , Basement Membrane/ultrastructure , Blood Glucose/metabolism , Blotting, Western , Body Weight , Diabetes Mellitus, Experimental/pathology , Fibronectins/metabolism , Intestine, Small/pathology , Intestine, Small/ultrastructure , Laminin/metabolism , Male , Muscle, Smooth/pathology , Muscle, Smooth/ultrastructure , Organ Size , Rats , Rats, Sprague-Dawley
11.
Zygote ; 8(2): 171-9, 2000 May.
Article in English | MEDLINE | ID: mdl-10857588

ABSTRACT

The aim of the present study was to determine the presence of the connexins Cx43, Cx32 and Cx26 in Bufo arenarum ovarian follicles during the breeding season as well as to analyse the possible alterations in the meiotic process when connexins are blocked by specific antibodies. Western blot analysis revealed that the Cx43 and Cx32 proteins were present but not Cx26. We demonstrated that the anti-Cx43 and anti-Cx32 antibodies produced the uncoupling of the gap junctions. When these junctions are blocked the maturation process is triggered in the oocytes. We determined that dbcAMP exerts an inhibitory effect on the maturation induced by the uncoupling of the gap junctions when the oocytes are injected or pretreated with this metabolite. We propose the idea that cAMP is the regulatory molecule in meiotic arrest in this amphibian species.


Subject(s)
Bufo arenarum/physiology , Cyclic AMP/metabolism , Gap Junctions/physiology , Meiosis , Ovarian Follicle/physiology , Animals , Antibodies, Monoclonal/pharmacology , Blotting, Western , Bucladesine/pharmacology , Connexin 26 , Connexin 43/immunology , Connexin 43/metabolism , Connexins/immunology , Connexins/metabolism , Female , Gap Junctions/drug effects , Ovarian Follicle/cytology , Progesterone/pharmacology , Gap Junction beta-1 Protein
12.
J Exp Zool ; 286(5): 457-72, 2000 Apr 01.
Article in English | MEDLINE | ID: mdl-10684569

ABSTRACT

In the present paper we established the ganglioside composition of the blastula and gastrula stages of the anuran amphibian Bufo arenarum, two relevant stages characterized by dynamic changes in morphology and cellular rearrangements. Densitometric studies evidenced that GD1a and GT1b were the more abundant gangliosides of the blastula embryos whereas GM1 and GM2 were the predominant species in gastrula embryos. Analysis of ganglioside abundance indicates that the "a" and "b" synthesis pathways perform similar biosynthetic activities in the blastula stage, in contrast to the gastrula stage in which a marked predominance of the "a" pathway occurred. The spatio-temporal expression of GM1 and of polygangliotetraosyl ceramides (pGTC) was investigated by wholemount immunocytochemistry using cholera toxin B subunit (CTB) and an affinity purified human anti-GM1 antibody. The pGTC were detected as GM1 after treatment with neuraminidase. Blastomeres from the inner surface of the blastocoelic roof (BCR) of blastula embryos were GM1 and pGTC positive. At midgastrula stage, embryos showed an increased labeling on the inner surface of BCR. To establish whether the GM1 ganglioside was involved in the gastrulation processes, CTB, anti-GM1 antibodies and anti-GM1 Fab' fragments were microinjected into the blastocoel cavity of blastula embryos. Treatment with the probes blocked gastrulation. Scanning electron microscopy analysis of blocked embryos revealed that mesodermal cell migration, radial interdigitation, and convergent extension movements were affected. The blocking of gastrulation was correlated with the absence of fibronectin and EP3/EP4 on the inner surface of blastocoelic roof of CTB- or anti-GM1 treated embryos. Results show that the GM1 ganglioside is differentially expressed by embryonic cells and participates in the morphogenetic processes of amphibian gastrulation. J. Exp. Zool. 286:457-472, 2000.


Subject(s)
Bufo arenarum/embryology , G(M1) Ganglioside/metabolism , Gastrula/physiology , Animals , Bufo arenarum/physiology , Chromatography, Thin Layer , Densitometry , Electrophoresis, Polyacrylamide Gel , Extracellular Matrix Proteins/metabolism , Gangliosides/analysis , Humans , Microinjections
13.
J Exp Zool ; 277(3): 181-97, 1997 Feb 15.
Article in English | MEDLINE | ID: mdl-9062995

ABSTRACT

We studied the presence and distribution of the extracellular materials (ECM), obtained by mild embryonic dissociation through nondenaturing and denaturing PAGE, immunoblotting and immunocytochemical wholemount in the gastrulation of anuran amphibian Bufo arenarum. The SDS-PAGE, under reducing conditions, revealed the protein profile of the ECM which comprised six bands. The Western immunoblotting effected with antibodies against fibronectins (FN) of Xenopus laevis, Ambystoma mexicanum and Bufo arenarum revealed that the 210 and 190 KDa bands (EP1-EP2) present in the ECM were identified as FN. Polyclonal antibodies against the 85-75 KDa polypeptides (EP3-EP4) were obtained and used throughout this study. The distribution of FN and EP3-EP4 was comparatively studied in the blastocoelic roof (BCR) of stage 10.5 Bufo arenarum, Xenopus laevis and Ambystoma mexicanum embryos. In the anurans, FN appeared as a network of fine fibrils apparently oriented at random, while in Ambystoma, FN appeared as a complex anastomosing network of oriented fibrils. EP3-EP4 were found in Bufo and in Xenopus both in the intercellular contact zones and in the cellular periphery. No linear arrangements of these proteins were observed. Few, if any, EP3-EP4 were found on the BCR of Ambystoma mexicanum. At stage 11, EP3-EP4, which showed a dramatic increase at the chordomesoderm-neuroectoderm junction in Bufo arenarum embryos, appeared as an amorphous material. For the purpose of analyzing the role of EP3-EP4 during Bufo arenarum gastrulation, anti-EP3-EP4 antibodies and anti-EP3-EP4 Fab fragments were microinjected into the blastocoel cavity of stage 9 embryos, an event that cause severe alterations in the gastrulation process. Convergent extension of the dorsal marginal zone and the epiboly of the BCR were the most strongly affected events. Results show that EP3-EP4 are required for normal Bufo arenarum gastrulation.


Subject(s)
Bufo arenarum/embryology , Extracellular Matrix Proteins/physiology , Gastrula/physiology , Animals , Antibodies , Antibody Specificity , Extracellular Matrix Proteins/analysis , Extracellular Matrix Proteins/chemistry , Fibronectins/analysis , Fibronectins/physiology , Gastrula/chemistry , Molecular Weight
14.
Int J Dev Biol ; 40(5): 997-1008, 1996 Oct.
Article in English | MEDLINE | ID: mdl-8946247

ABSTRACT

In the present study, we analyzed the localization of vitronectin-like protein in oocytes during oogenesis as well as in the serum and liver tissue of the amphibian Bufo arenarum. Vitronectin-like protein was purified from serum by heparin-affinity chromatography and showed to have the two biological properties in common with most animal vitronectins (VN): heparin binding activity and an RGD-dependent cell-spreading activity. SDS-PAGE of vitronectin-like protein revealed that it consists of two bands of 64 kDa and 72 kDa, while immunoblotting analyses showed that this protein strongly cross-reacts with two monoclonal antibodies against human VN. No immunofluorescent staining of vitronectin-like protein was observed in previtellogenic oocytes (stages I and II). In vitellogenic oocytes (stages III, IV and V) fluorescence was observed in the cortical cytoplasm localized in yolk platelets, extending concomitantly with the vitellogenic process. When we examined the yolk platelet formation pathway by immunoelectron microscopy, gold particles indicated that vitronectin-like protein was located on the yolk platelet precursors: multivesicular bodies and primordial yolk platelets. Gold particles also were seen sparsely distributed in all oocyte investing layers. The mean serum vitronectin-like protein concentration in amphibian animals was 127.8 +/- 11.6 micrograms/ml in adult males and 181.5 +/- 14.3 micrograms/ml in adult females. Serum vitronectin-like protein of males and females was susceptible to hormonal stimulation (17-beta estradiol). These results suggest that vitronectin-like protein is stored in the yolk platelets and may be involved in the later events of amphibian development.


Subject(s)
Bufo arenarum/metabolism , Oocytes/growth & development , Vitronectin/metabolism , Animals , Antibodies/immunology , Antibodies/pharmacology , Blotting, Western , Cell Movement/drug effects , Cells, Cultured , Electrophoresis, Polyacrylamide Gel , Estradiol/pharmacology , Female , Fluorescent Antibody Technique , Immunohistochemistry , Male , Microscopy, Immunoelectron , Peptides/pharmacology , Vitronectin/blood , Vitronectin/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...